Literature DB >> 11758639

Treatment of osteoporosis among older adults discharged from hospital in Italy.

G Onder1, C Pedone, G Gambassi, F Landi, M Cesari, R Bernabei.   

Abstract

OBJECTIVE: Osteoporosis and its complications represent one of the most important causes of morbidity and mortality among the elderly. Despite the availability of several drugs deemed effective at reducing the incidence of fractures, only a minority of patients receive pharmacological treatment. We studied patients with a diagnosis of osteoporosis at discharge from hospital in Italy to identify predictors of receiving specific pharmacological treatment and to analyse how the pattern of drug prescription has changed in the last decade.
METHODS: We analysed data from a multicentre pharmacoepidemiology study that collected data on hospitalised patients throughout Italy. Patients with a diagnosis of osteoporosis admitted during five different surveys in 1988, 1991, 1993, 1995 and 1997 were considered for the present study.
RESULTS: Of 863 patients with a diagnosis of osteoporosis, 461 (53.4%) received treatment. Age [odds ratio (OR) 0.86 for each decade of increment, 95% confidence interval (CI) 0.73, 0.99], male gender (OR 0.67, 95% CI 0.44, 0.99), number of comorbid conditions (4-5 vs. 0-3 conditions: OR 0.66, 95% CI 0.47, 0.91; 6 or more vs. 0-3 conditions: OR 0.47, 95% CI 0.31, 0.72) and number of medications (OR 0.92 for each drug increase, 95% CI 0.85, 0.99) were all associated with a reduced likelihood of receiving pharmacological treatment for osteoporosis. In contrast, concomitant corticosteroid use (OR 2.00, 95% CI 1.05, 3.80), admission for hip or vertebral fracture (OR 2.10, 95% Cl 1.12, 3.93) and year of survey (OR 1.11, 95% CI 1.01, 1.24) were independent predictors of a higher treatment rate. Among individual drugs, calcitonin use remarkably declined from 42.1% in 1988 to 0.8% in 1997 (P for trend <0.001), while bisphosphonate prescriptions increased from 1.3% in 1988 to 34.9% in 1997 (P for trend <0.001). Prescription of calcium did not change significantly throughout the decade examined, while vitamin D had a twofold increase (14.2% in 1988 to 26.2% in 1997, P for trend <0.001).
CONCLUSIONS: Among patients discharged from hospital in Italy, osteoporosis is an uncommon diagnosis. Even when the diagnosis is made, osteoporosis is often undertreated, and treatment is reserved for younger and less medically complex patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11758639     DOI: 10.1007/s002280100370

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

1.  Inappropriate medication use among hospitalized older adults in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly.

Authors:  Graziano Onder; Francesco Landi; Matteo Cesari; Giovanni Gambassi; Pierugo Carbonin; Roberto Bernabei
Journal:  Eur J Clin Pharmacol       Date:  2003-05-07       Impact factor: 2.953

2.  Hip fracture and other predictors of anti-osteoporosis drug use in Norway.

Authors:  H M Devold; A J Søgaard; A Tverdal; J A Falch; K Furu; H E Meyer
Journal:  Osteoporos Int       Date:  2012-07-10       Impact factor: 4.507

3.  Incidence and causes for failure of treatment of women with proven osteoporosis.

Authors:  Noah Zafran; Zvi Liss; Ronit Peled; Michael Sherf; Haim Reuveni
Journal:  Osteoporos Int       Date:  2005-04-02       Impact factor: 4.507

4.  Physical performance measures and polypharmacy among hospitalized older adults: results from the CRIME study.

Authors:  F Sganga; D L Vetrano; S Volpato; A Cherubini; C Ruggiero; A Corsonello; P Fabbietti; F Lattanzio; R Bernabei; G Onder
Journal:  J Nutr Health Aging       Date:  2014       Impact factor: 4.075

Review 5.  Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review.

Authors:  V Elliot-Gibson; E R Bogoch; S A Jamal; D E Beaton
Journal:  Osteoporos Int       Date:  2004-07-16       Impact factor: 4.507

6.  The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture.

Authors:  Alastair R McLellan; Stephen J Gallacher; Mayrine Fraser; Carol McQuillian
Journal:  Osteoporos Int       Date:  2003-11-05       Impact factor: 4.507

7.  Characteristics associated with anti-osteoporosis medication use: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort.

Authors:  Pamela Guggina; Julie Flahive; Frederick H Hooven; Nelson B Watts; Ethel S Siris; Stuart Silverman; Christian Roux; Johannes Pfeilschifter; Susan L Greenspan; Adolfo Díez-Pérez; Cyrus Cooper; Juliet E Compston; Roland Chapurlat; Steven Boonen; Jonathan D Adachi; Frederick A Anderson; Stephen Gehlbach
Journal:  Bone       Date:  2012-09-03       Impact factor: 4.398

8.  Socioeconomic status and hospitalization in the very old: a retrospective study.

Authors:  Raffaele Antonelli-Incalzi; Carla Ancona; Francesco Forastiere; Valeria Belleudi; Andrea Corsonello; Carlo A Perucci
Journal:  BMC Public Health       Date:  2007-08-31       Impact factor: 3.295

Review 9.  The osteoporosis care gap in Canada.

Authors:  A Papaioannou; L Giangregorio; B Kvern; P Boulos; G Ioannidis; J D Adachi
Journal:  BMC Musculoskelet Disord       Date:  2004-04-06       Impact factor: 2.362

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.